Detalhe da pesquisa
1.
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
Am J Hum Genet
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723632
2.
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
N Engl J Med
; 390(12): 1080-1091, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507751
3.
The impact of coding germline variants on contralateral breast cancer risk and survival.
Am J Hum Genet
; 110(3): 475-486, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36827971
4.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139274
5.
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Int J Cancer
; 155(1): 128-138, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447007
6.
Genome-wide association study and functional follow-up identify 14q12 as a candidate risk locus for cervical cancer.
Hum Mol Genet
; 31(15): 2483-2497, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157032
7.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat
; 204(2): 237-248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112922
8.
Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization.
Breast Cancer Res Treat
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653906
9.
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.
Clin Chem
; 70(1): 307-318, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175595
10.
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective.
Strahlenther Onkol
; 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38393398
11.
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Gynecol Oncol
; 183: 25-32, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490057
12.
Association between event-free survival and overall survival in early-stage triple-negative breast cancer.
Future Oncol
; 20(6): 335-348, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602372
13.
Effects of prenatal alcohol exposition on cognitive outcomes in childhood and youth: a longitudinal analysis based on meconium ethyl glucuronide.
Eur Arch Psychiatry Clin Neurosci
; 274(2): 343-352, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532863
14.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129136
15.
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Lancet Oncol
; 24(9): 1029-1041, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657462
16.
A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to BRCA1 and BRCA2.
Hum Mutat
; 20232023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38725546
17.
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Breast Cancer Res
; 25(1): 93, 2023 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559094
18.
Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes BReast CAncer 1 and BReast CAncer 2.
Curr Issues Mol Biol
; 45(8): 6618-6633, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37623237
19.
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Am J Hum Genet
; 107(5): 837-848, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022221
20.
Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review.
Oncologist
; 28(10): e847-e858, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536278